614 related articles for article (PubMed ID: 29964135)
1. Polymer-based carriers for ophthalmic drug delivery.
Imperiale JC; Acosta GB; Sosnik A
J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
[TBL] [Abstract][Full Text] [Related]
2. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
Mandal A; Bisht R; Rupenthal ID; Mitra AK
J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.
Almeida H; Amaral MH; Lobao P; Frigerio C; Sousa Lobo JM
Curr Pharm Des; 2015; 21(36):5212-24. PubMed ID: 26412360
[TBL] [Abstract][Full Text] [Related]
5. In Situ Gelling Ophthalmic Drug Delivery System: An Overview and Its Applications.
Sheshala R; Kok YY; Ng JM; Thakur RR; Dua K
Recent Pat Drug Deliv Formul; 2015; 9(3):237-48. PubMed ID: 26205681
[TBL] [Abstract][Full Text] [Related]
6. Ocular application of chitosan.
Başaran E; Yazan Y
Expert Opin Drug Deliv; 2012 Jun; 9(6):701-12. PubMed ID: 22530690
[TBL] [Abstract][Full Text] [Related]
7. Cell penetrating peptides in ocular drug delivery: State of the art.
Pescina S; Ostacolo C; Gomez-Monterrey IM; Sala M; Bertamino A; Sonvico F; Padula C; Santi P; Bianchera A; Nicoli S
J Control Release; 2018 Aug; 284():84-102. PubMed ID: 29913221
[TBL] [Abstract][Full Text] [Related]
8. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
[TBL] [Abstract][Full Text] [Related]
9. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
Fangueiro JF; Veiga F; Silva AM; Souto EB
Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
[TBL] [Abstract][Full Text] [Related]
10. Ophthalmic drug delivery systems--recent advances.
Bourlais CL; Acar L; Zia H; Sado PA; Needham T; Leverge R
Prog Retin Eye Res; 1998 Jan; 17(1):33-58. PubMed ID: 9537794
[TBL] [Abstract][Full Text] [Related]
11. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
[TBL] [Abstract][Full Text] [Related]
12. Novel Ocular Drug Delivery Systems: An Update on Microemulsions.
Üstündağ Okur N; Çağlar EŞ; Siafaka PI
J Ocul Pharmacol Ther; 2020; 36(6):342-354. PubMed ID: 32255728
[TBL] [Abstract][Full Text] [Related]
13. Ocular drug delivery-eye on innovation.
Rupenthal ID; O'Rourke M
Drug Deliv Transl Res; 2016 Dec; 6(6):631-633. PubMed ID: 27766597
[No Abstract] [Full Text] [Related]
14. Hyaluronic acid in ocular drug delivery.
Zhang X; Wei D; Xu Y; Zhu Q
Carbohydr Polym; 2021 Jul; 264():118006. PubMed ID: 33910737
[TBL] [Abstract][Full Text] [Related]
15. Delivery of therapeutics for deep-seated ocular conditions - status quo.
Nguyen H; Eng S; Ngo T; Dass CR
J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
[TBL] [Abstract][Full Text] [Related]
16. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.
Shen J; Lu GW; Hughes P
Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364
[TBL] [Abstract][Full Text] [Related]
17. A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems.
Andonova VY
Curr Pharm Des; 2016; 22(41):6313-6329. PubMed ID: 27526789
[TBL] [Abstract][Full Text] [Related]
18. In vitro testing of thiolated poly(aspartic acid) from ophthalmic formulation aspects.
Budai-Szű Cs M; Horvát G; Gyarmati B; Szilágyi BÁ; Szilágyi A; Csihi T; Berkó S; Szabó-Révész P; Mori M; Sandri G; Bonferoni MC; Caramella C; Csányi E
Drug Dev Ind Pharm; 2016 Aug; 42(8):1241-6. PubMed ID: 26556306
[TBL] [Abstract][Full Text] [Related]
19. In situ gel systems as 'smart' carriers for sustained ocular drug delivery.
Agrawal AK; Das M; Jain S
Expert Opin Drug Deliv; 2012 Apr; 9(4):383-402. PubMed ID: 22432690
[TBL] [Abstract][Full Text] [Related]
20. In situ gelling polymers in ocular drug delivery systems: a review.
Mundada AS; Avari JG
Crit Rev Ther Drug Carrier Syst; 2009; 26(1):85-118. PubMed ID: 19496748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
